logo
Plus   Neg
Share
Email

After Market Hours: MDC Partners, Ekso Bionics, Nike, Virgin Galactic Gain; Soliton Slips

MDC Partners Inc. (MDCA) - Shares of the company soared over 165% on extended trading hours Thursday after Stagwell Media LP announced that it has proposed a combination with MDC Partners. The proposal values MDC shares at $4.25 per share, which gives a premium of 263% to MDC's closing price of $1.17 per share on June 24, 2020.

Ekso Bionics Holdings, Inc. (EKSO) - Shares of the exoskelton maker jumped about 40% in extended trading session on top of 135% gain in regular trading Thursday. The company said it received 501 clearance from the U.S. FDA to market its EksoNR robotic exoskeleton for use in patients with acquired brain injury, or ABI. The device is first to get FDA clearance for use with ABI.

Vaxart, Inc. (VXRT) - Shares of the clinical-stage biotechnology company jumped 25% on extended trading session on top of 96% gained in regular trading Thursday. The company said it signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP (AMS) to use AMS' resources for lyophilization development and large scale manufacturing including tableting and enteric coating for Vaxart's oral COVID-19 vaccine.

Virgin Galactic Holdings Inc. (SPCE) - Shares of the space company gained 6% in extended trading session after it announced that it successfully completed its second glide flight test of its spaceship over Spaceport America in New Mexico. The company said it is now preparing for full rocket-powered test flights and expects to begin commercial operations this summer.

Nike Inc. (NKE) - Shares of the sports apparel maker slipped nearly 4% in after hours trading after Nike's fourth-quarter results missed Street view. Nike reported a loss of $790 million or $0.51 per share on revenues of $6.31 billion, compared to last year's profit of $989 million or $0.62 per share on revenues of $10.18 billion last year. Analysts polled by Thomson Reuters estimated earnings of $0.09 per share on revenues of $7.52 billion. The company said recorded sales decline of 38%, hurt largely by store closures due to the coronavirus pandemic.

Soliton, Inc. (SOLY) - Shares of the medical device maker tanked 15% in after-hours Thursday after it announced plans to offer shares in a public offering. The company did not reveal the actual size or terms of the offering.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies. Beverages giant Coca-Cola reported a 19 percent decline in profit for the second quarter from last year as a revenue growth of 5 percent and improved margins were offset by higher income taxes and interest expense. However, adjusted earnings per share and revenues topped analysts' expectations. The company also maintained its adjusted earnings and organic revenue growth outlook for fiscal 2021.
Follow RTT